REGILLO, CARL MD
Ophthalmology · NPI 1740248038 · PLYMOUTH MEETING, PA
REGILLO, CARL is a Ophthalmology in PLYMOUTH MEETING, PA, a member of 2 medical groups, who billed 21 distinct codes to Medicare Part B in 2024.
Groups: ASSOCIATED RETINAL SURGEONS, PA (CHERRY HILL, NJ) · RETINOVITREOUS ASSOCIATES LTD (PHILADELPHIA, PA) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider analytics (2024)
REGILLO, CARL billed 54,345 disclosed services in CY2023 and 72,266 in CY2024.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | premium | premium | premium | premium |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | premium | premium | premium | premium |
| 92134 | Imaging of retina | premium | premium | premium | premium |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | premium | premium | premium | premium |
| 67028 | Injection of drug into eye | premium | premium | premium | premium |
| 92012 | Established patient problem focused exam of visual system | premium | premium | premium | premium |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | premium | premium | premium | premium |
| J0178 | Injection, aflibercept, 1 mg | premium | premium | premium | premium |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | premium | premium | premium | premium |
| 92014 | Established patient complete exam of visual system | premium | premium | premium | premium |
| J0177 | Injection, aflibercept hd, 1 mg | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| J3590 | Unclassified biologics | premium | premium | premium | premium |
| 92201 | Extended exam of the back part of the eye with retinal drawing | premium | premium | premium | premium |
| J7999 | Compounded drug, not otherwise classified | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 76512 | 2d ultrasound scan of eye tissue and structures | premium | premium | premium | premium |
| 92250 | Photography of the retina | premium | premium | premium | premium |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | premium | premium | premium | premium |
| 99205 | New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | premium | premium | premium | premium |
| 67145 | Photocoagulation treatment to prevent detachment of retina | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.